|
|
|
|
ASH 49th Annual Meeting Itinerary: Abstracts pertinent to cord blood transplantation Monday, December 10, 2007 Session Information: Simultaneous Session: Experimental Transplantation: Basic Biology and Engraftment (7:30 a.m.- 9:00 a.m.) Presentation Time: 7:45 am Title: [176] An Animal Model That Predicts Unit Engraftment in Double Unit Cord Blood Transplant Recipients. Session Type: Oral Session Session Information: Simultaneous Session: Clinical Results: Alternative Donor Transplantation-Matched Unrelated Donors and Comparative Studies (7:30 a.m.-9:00 a.m.) Presentation Time: 8:15 am Title: [172] Comparable Outcome after Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated and Sibling Donors in Elderly Patients with Acute Myeloid Leukemia - Results of a Retrospective Analysis in 368 Patients. Session Type: Oral Session Session Information: Simultaneous Session: Clinical Results: Alternative Donor Transplantation-Umbilical Cord Blood and Comparative Studies, Selection Criteria, and New Approaches (11:00 a.m.-12:30 p.m.) Presentation Time: 11:00 am Title: [331] Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor. Session Type: Oral Session Presentation Time: 11:15 am Title: [332] Comparison of 6586 Unrelated Bone Marrow Transplants (UBMT) and 2713 Unrelated Cord Blood Transplants (UCBT) in Japan. Session Type: Oral Session Session Information: Simultaneous Session: Experimental Transplantation: Suppression of GVHD (11:00 a.m.-12:30 p.m.) Title: [350] In Vivo Activated CD103+CD4+ Regulatory T Cells Ameliorate Ongoing Chronic GVHD. Session Type: Oral Session Session Information: Simultaneous Session: Clinical Results: Alternative Donor Transplantation-Umbilical Cord Blood and Comparative Studies, Selection Criteria, and New Approaches (11:00 a.m.-12:30 p.m.) Presentation Time: 11:30 am Title: [333] The Dose-Match Interaction in Umbilical Cord Blood (UCB) Transplantation: An Analysis of the Impact of Cell Dose and HLA−Match on the Disease−Free Survival (DFS) of 989 Patients Transplanted with Single Units for Hematologic Malignancy. Session Type: Oral Session Title: [334] Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients. Session Type: Oral Session Session Information: Poster Session: Acute Lymphocytic Leukemia: Biology and Pathophysiology (5:00 p.m.-7:00 p.m.) Presentation Time: 5:00 pm Title: [2803] KIRs Expression and Cytotoxic Activities of Cord Blood Natural Killer Cells Against Acute Lymphoblastic Leukemia with MLL Gene Rearrangement. Session Type: Poster Session, Board #22-III Session Information: Poster Session: Acute Myeloid Leukemias: Therapy, excluding Transplantation III (5:00 p.m.-7:00 p.m.) Title: [2863] Evaluation of Clinical Judgement at Initiation of AML-Therapy in Elderly Patients - A Prospective Randomized Trial. Session Type: Poster Session, Board #82-III Session Information: Poster Session: Clinical Care: Acute and Chronic GVHD, Infectious Complications, and Immune Reconstitution of Transplantation III (5:00 p.m.-7:00 p.m.) Title: [2977] Graft-Versus-Host Disease (GVHD) in Cord Blood Transplantation (CBT): Risk Factors, Clinical Manifestations and Outcomes. Session Type: Poster Session, Board #196--III Title: [2981] Iron Overload Adversely Affects Survival and Increases Risk of Graft-Versus-Host Disease and Blood Stream Infections after Allogeneic Hematopoietic Stem Cell Transplantation. Session Type: Poster Session, Board #200-III Title: [2992] IL-7 along with Optimized CD3/CD28 Artificial APC Beads Promotes Ex Vivo Expansion of Cord Blood T Cells towards Adoptive Immunotherapy. Session Type: Poster Session, Board #211-III Session Information: Poster Session: Clinical Results: Alternative Donor Transplantation-Matched Unrelated Donors and Haploidentical Transplants (5:00 p.m.-7:00 p.m.) Title: [3051] A Comparison of 1 Antigen-Mismatched Related and Matched Unrelated Transplants. Session Type: Poster Session, Board #270-III Title: [3063] Rapid Transport and Infusion of Hematopoietic Stem Cells Can Improve Outcome after Unrelated Donor Transplant. Session Type: Poster Session, Board #282-III Session Information: Poster Session: Experimental Transplantation: Immune Tolerance, Regulatory T-Cells, Immune Recovery, and Alloreactivity (5:00 p.m.-7:00 p.m.) Title: [3272] Cord Blood NK Cytotoxic Activity Can Be Selelctively Modulated by Accessory. Session Type: Poster Session, Board #491-III Session Information: Poster Session: Hematologic Malignancies and Treatment Complications (5:00 p.m.-7:00 p.m.) Title: [3329] Hematopoietic Stem Cell Transplantation from Sibling or Autologous Cord Blood Units: Report from a Single Cord Blood Unit (CBU) Bank. Session Type: Poster Session, Board #548-III Session Information: Poster Session: Hematopoiesis: Apoptosis and Cell Cycle Regulation (5:00 p.m.- 7:00 p.m.) Title: [3367] Selected Members of the Angiopoietin-Like Family of Human Proteins Enhance Survival and Replating Capacity of Immature Human Hematopoietic Progenitor Cells. Session Type: Poster Session, Board #586-III Session Information: Poster Session: Stem Cell Plasticity (5:00 p.m.-7:00 p.m.) Title: [3697] Outgrowing Endothelial Cells That Are Derived from Human Umbilical Cord Blood Improve Neovascularization in Hind-Limb Ischemia. Session Type: Poster Session, Board #916-III Session Information: Poster Session: Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion (5:00 p.m.-7:00 p.m.) Title: [3714] Human Cord Blood-Derived Endothelial Progenitor Cells Engraft Following In Utero Transplantation, Integrate into the Developing Cytoarchitecture and Contribute to Ongoing Vasculogenesis. Session Type: Poster Session, Board #933-III
|
|
|
|
|
|
Page Updated
22 Nov 2007 |
Disclaimer: The Cord Blood Forum endorses collegial discussion among cord blood transplantation professionals, patients and donors. However, the Cord Blood Forum does not necessarily endorse, nor take any responsibility for the specific views and opinions expressed in the forum. The forum is not intended as a substitute for legal and/or medical advice and the content should not be relied upon for medical and/or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting with an attorney familiar with related state and federal laws.
© 2008 Cord Blood Forum, Inc. 1601 N. Sepulveda Blvd. #729, Manhattan Beach, CA 90266 |
![]() |
![]() |